These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 2447215)
1. Comparison of properties of monoclonal and polyclonal antibodies against the light chain of human high molecular weight kininogen. Kleniewski J; Dingle S; Donaldson VH J Lab Clin Med; 1988 Jan; 111(1):93-103. PubMed ID: 2447215 [TBL] [Abstract][Full Text] [Related]
2. Mechanism of enhanced kinin release from high molecular weight kininogen by plasma kallikrein after its exposure to plasmin. Kleniewski J; Blankenship DT; Cardin AD; Donaldson V J Lab Clin Med; 1992 Jul; 120(1):129-39. PubMed ID: 1535355 [TBL] [Abstract][Full Text] [Related]
3. Cleavage of human high-molecular weight kininogen by purified kallikreins and upon contact activation of plasma. Reddigari S; Kaplan AP Blood; 1988 May; 71(5):1334-40. PubMed ID: 2451949 [TBL] [Abstract][Full Text] [Related]
4. Determination of the bifunctional properties of high molecular weight kininogen by studies with monoclonal antibodies directed to each of its chains. Schmaier AH; Schutsky D; Farber A; Silver LD; Bradford HN; Colman RW J Biol Chem; 1987 Jan; 262(3):1405-11. PubMed ID: 2433279 [TBL] [Abstract][Full Text] [Related]
5. Quantification of human high molecular weight kininogen by immunoblotting with a monoclonal anti-light chain antibody. Reddigari S; Kaplan AP J Immunol Methods; 1989 Apr; 119(1):19-25. PubMed ID: 2651524 [TBL] [Abstract][Full Text] [Related]
6. Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A. Pfitzner SA; Dempfle CE; Matsuda M; Heene DL Thromb Haemost; 1997 Sep; 78(3):1069-78. PubMed ID: 9308756 [TBL] [Abstract][Full Text] [Related]
7. The sequence HGLGHGHEQQHGLGHGH in the light chain of high molecular weight kininogen serves as a primary structural feature for zinc-dependent binding to an anionic surface. DeLa Cadena RA; Colman RW Protein Sci; 1992 Jan; 1(1):151-60. PubMed ID: 1304876 [TBL] [Abstract][Full Text] [Related]
8. Production and characterization of monoclonal antibodies directed against high and low molecular weight kininogens. Hentges F; Kohnen M; Grigioni F; Reichert P; Humbel R; Schneider F Bull Soc Sci Med Grand Duche Luxemb; 1994; 131(2):9-17. PubMed ID: 7820912 [TBL] [Abstract][Full Text] [Related]
9. The role of prekallikrein and high-molecular-weight kininogen in the contact activation of Hageman factor (factor XII) by sulfatides and other agents. España F; Ratnoff OD J Lab Clin Med; 1983 Oct; 102(4):487-99. PubMed ID: 6604770 [TBL] [Abstract][Full Text] [Related]
10. Insights on monoclonal antibodies to kininogens' heavy chain which influence kininogens' binding to platelets. Jiang Y; Nawarawong W; Meloni FJ; Schmaier AH Thromb Haemost; 1992 Aug; 68(2):143-8. PubMed ID: 1412158 [TBL] [Abstract][Full Text] [Related]
12. Inactivation of human high molecular weight kininogen by human mast cell tryptase. Maier M; Spragg J; Schwartz LB J Immunol; 1983 May; 130(5):2352-6. PubMed ID: 6339626 [TBL] [Abstract][Full Text] [Related]
13. Monoclonal IgG3 (kappa) antibodies against murine Thy-1.2 antigen produced by murine hybridomas. Differences in the specificity of the antigen binding site and in the structure of the hinge region. Zikán J; Dráber P; Vojtísková M Folia Biol (Praha); 1982; 28(6):377-94. PubMed ID: 6186535 [TBL] [Abstract][Full Text] [Related]
14. Structural characterization of human melanoma-associated antigen p97 with monoclonal antibodies. Brown JP; Nishiyama K; Hellström I; Hellström KE J Immunol; 1981 Aug; 127(2):539-46. PubMed ID: 6166674 [TBL] [Abstract][Full Text] [Related]
15. [Single-chain, low molecular weight kininogen in the blood plasma of rabbits: isolation and fragmentation by porcine pancreatic kallikrein]. Levina GO; Makevnina LG; Sherstiuk SF; Paskhina TS Biokhimiia; 1985 Feb; 50(2):325-36. PubMed ID: 3845817 [TBL] [Abstract][Full Text] [Related]
16. Characterization of the procoagulant chain derived from human high molecular weight kininogen (Fitzgerald factor) by human tissue kallikrein. Maier M; Austen KF; Spragg J Blood; 1983 Aug; 62(2):457-63. PubMed ID: 6553501 [TBL] [Abstract][Full Text] [Related]
17. Mapping of functional domains of human high molecular weight and low molecular weight kininogens using murine monoclonal antibodies. Ishiguro H; Higashiyama S; Ohkubo I; Sasaki M Biochemistry; 1987 Nov; 26(22):7021-9. PubMed ID: 2447941 [TBL] [Abstract][Full Text] [Related]
18. Studies on human high molecular weight (HMW) kininogen. II. Structural change of HMW kininogen by the action of human plasma kallikrein. Mori K; Nagasawa S J Biochem; 1981 May; 89(5):1465-73. PubMed ID: 6168636 [TBL] [Abstract][Full Text] [Related]
19. Radioimmunoassays of human high and low molecular weight kininogens in plasmas and platelets. Kerbiriou-Nabias DM; Garcia FO; Larrieu MJ Br J Haematol; 1984 Feb; 56(2):273-86. PubMed ID: 6691922 [TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibody to human high-molecular-weight kininogen recognizes its prekallikrein binding site and inhibits its coagulant activity. Reddigari SR; Kaplan AP Blood; 1989 Aug; 74(2):695-702. PubMed ID: 2752143 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]